Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd. Common Stock (MDCX) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
mdcx · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Medicus Pharma Ltd. Common Stock (MDCX) measures how much investors pay for each dollar of the company's trailing earnings. MDCX's current PE ratio of N/A is calculated by dividing its stock price of $0.34 by its TTM earnings per share of -$1.25.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2021 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Medicus Pharma Ltd. Common StockYou MDCX | $7M | N/A | — | -$1.25 |
 Aligos Therapeutics, Inc. ALGS | $32M | N/A | — | -$2.45 |
 Barinthus Biotherapeutics plc BRNS | $30M | N/A | — | -$1.64 |
 Coeptis Therapeutics, Inc. COEP | $58M | N/A | — | -$2.81 |
 Cue Biopharma, Inc. CUE | $79M | N/A | — | -$8.42 |
 CEL-SCI Corporation CVM | $10M | N/A | — | -$6.27 |
 INmune Bio, Inc. INMB | $34M | N/A | — | -$1.73 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-1.47 | — | |
2024-12-31 FY2024 | — | $-1.16 | — | |
2023-12-31 FY2023 | — | $-1.53 | — | |
2022-12-31 FY2022 | — | $-0.88 | — | |
2021-12-31 FY2021 | — | $-0.26 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Medicus Pharma Ltd. Common Stock (MDCX) measures how much investors pay for each dollar of the company's trailing earnings. MDCX's current PE ratio of N/A is calculated by dividing its stock price of $0.34 by its TTM earnings per share of -$1.25.
Frequently asked questions
MDCX pe ratio · 6 questionsMDCX's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.34 and TTM EPS of -$1.25. Data sourced from Financial Modeling Prep via MDCX's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Medicus Pharma Ltd. Common Stock SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09